<DOC>
	<DOCNO>NCT01619878</DOCNO>
	<brief_summary>The purpose study obtain efficacy , safety pharmacokinetic ( PK ) data follow treatment artemether-lumefantrine dispersible tablet infant &lt; 5 kg body weight ( BW ) uncomplicated falciparum malaria .</brief_summary>
	<brief_title>Efficacy , Safety Pharmacokinetics Artemether-lumefantrine Dispersible Tablet Treatment Malaria Infants &lt; 5 kg</brief_title>
	<detailed_description />
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<mesh_term>Lumefantrine</mesh_term>
	<mesh_term>Artemether</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Artemether-lumefantrine combination</mesh_term>
	<criteria>Neonates / infant Body weight &lt; 5 kg In cohort 1 , infant age &gt; 28 day ; cohort 2 , neonate term age 0 ≤ 28 day Microscopically confirm diagnosis acute uncomplicated Plasmodium falciparum malaria mixed infection asexual Plasmodium falciparum parasitaemia &gt; 1,000 &lt; 100,000 parasites/µL Presence severe malaria ( accord World Health Organization definition ) Presence follow sign critical condition : apneabradycardia , sustain bradycardia , tachycardia , desaturation , hypotension , hypothermia ; severely deteriorate general condition ( base IMCI criterion sick infant ) Presence clinically significant neurological condition Presence clinically significant abnormality hepatic renal system Patients sustain significant blood volume loss ( &gt; 3 % calculated blood volume ) past 30 day Patients unable swallow whose drinking impaired Family history congenital prolongation QTc interval sudden death clinical condition know associated prolongation QTc interval history symptomatic cardiac arrhythmia , clinically relevant bradycardia severe cardiac disease Disturbances electrolyte balance ( e.g . hypokalaemia hypomagnesaemia ) Presence ageadjusted clinically hematologically relevant laboratory blood chemistry abnormalities Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>plasmodium</keyword>
	<keyword>P. falciparum</keyword>
	<keyword>malaria</keyword>
	<keyword>infant</keyword>
	<keyword>neonate</keyword>
</DOC>